Cisplatin Treatment Options in Canada

A collection of 326 research studies where Cisplatin is the interventional treatment. These studies are located in the Canada . Cisplatin is used for conditions such as Head and Neck Cancer, Lung Cancer and Non-small Cell Lung Cancer.

Home

Canada

All Treatments

Cisplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

NCT05180097

Recruiting

This study is being done to determine if two new drugs can shrink or eliminate classical Hodgkins lymphoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

05/12/2025

Locations: Concord Repatriation General Hospital, Concord, New South Wales +16 locations

Conditions: Hodgkin Lymphoma

Learn More ›

A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma

NCT01878617

Active Not Recruiting

Historically, medulloblastoma treatment has been determined by the amount of leftover disease present after surgery, also known as clinical risk (standard vs. high risk). Recent studies have shown that medulloblastoma is made up of distinct molecular subgroups which respond differently to treatment. This suggests that clinical risk alone is not adequate to identify actual risk of recurrence. In order to address this, we will stratify medulloblastoma treatment in this phase II clinical trial based on both clinical risk (low, standard, intermediate, or high risk) and molecular subtype (WNT, SHH, or Non-WNT Non-SHH). This stratified clinical and molecular treatment approach will be used to evaluate the following: * To find out if participants with low-risk WNT tumors can be treated with a lower dose of radiation to the brain and spine, and a lower dose of the chemotherapy drug cyclophosphamide while still achieving the same survival rate as past St. Jude studies with fewer side effects. * To find out if adding targeted chemotherapy after standard chemotherapy will benefit participants with SHH positive tumors. * To find out if adding new chemotherapy agents to the standard chemotherapy will improve the outcome for intermediate and high risk Non-WNT Non-SHH tumors. * To define the cure rate for standard risk Non-WNT Non-SHH tumors treated with reduced dose cyclophosphamide and compare this to participants from the past St. Jude study. All participants on this study will have surgery to remove as much of the primary tumor as safely possible, radiation therapy, and chemotherapy. The amount of radiation therapy and type of chemotherapy received will be determined by the participant's treatment stratum. Treatment stratum assignment will be based on the tumor's molecular subgroup assignment and clinical risk. The participant will be assigned to one of three medulloblastoma subgroups determined by analysis of the tumor tissue for tumor biomarkers: * WNT (Strata W): positive for WNT biomarkers * SHH (Strata S): positive for SHH biomarkers * Non-WNT Non-SHH, Failed, or Indeterminate (Strata N): negative for WNT and SHH biomarkers or results are indeterminable Participants will then be assigned to a clinical risk group (low, standard, intermediate, or high) based on assessment of: * How much tumor is left after surgery * If the cancer has spread to other sites outside the brain \[i.e., to the spinal cord or within the fluid surrounding the spinal cord, called cerebrospinal fluid (CSF)\] * The appearance of the tumor cells under the microscope * Whether or not there are chromosomal abnormalities in the tumor, and if present, what type (also called cytogenetics analysis) Read Less

Gender:

ALL

Ages:

Between 3 years and 39 years

Trial Updated:

05/01/2025

Locations: Lucille Packard Children's Hospital at Stanford University Medical Center, Palo Alto, California +22 locations

Conditions: Medulloblastoma

Learn More ›

A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer

NCT03288545

Active Not Recruiting

This study will test an experimental drug (enfortumab vedotin) alone and with different combinations of anticancer therapies. Pembrolizumab is an immune checkpoint inhibitor (CPI) that is used to treat patients with cancer of the urinary system (urothelial cancer). This type of cancer includes cancer of the bladder, renal pelvis, ureter or urethra. Some parts of the study will look at locally advanced or metastatic urothelial cancer (la/mUC), which means the cancer has spread to nearby tissues o... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/30/2025

Locations: Alaska Urological Institute, Anchorage, Alaska +105 locations

Alaska Urological Institute, Anchorage, Alaska

Banner MD Anderson Cancer Center, Gilbert, Arizona

Mayo Clinic Arizona, Phoenix, Arizona

Arizona Oncology Associates, PC - HOPE, Tucson, Arizona

Highlands Oncology Group, Fayetteville, Arkansas

Tower Hematology Oncology Medical Group, Beverly Hills, California

UC San Diego / Moores Cancer Center, La Jolla, California

University of California Irvine - Newport, Orange, California

University of California, Davis Comprehensive Cancer Center, Sacramento, California

University of California at San Francisco, San Francisco, California

Saint Joseph Heritage Medical Group, Santa Rosa, California

Stanford Cancer Center / Blood & Marrow Transplant Program, Stanford, California

Kaiser Permanente Southern California, Woodland Hills, California

Rocky Mountain Cancer Centers - Aurora, Aurora, Colorado

University of Colorado Hospital / University of Colorado, Aurora, Colorado

Yale Cancer Center, New Haven, Connecticut

Eastern CT Hematology and Oncology Associates, Norwich, Connecticut

Georgetown University Medical Center, Washington, District of Columbia

Boca Raton Regional Hospital / Lynn Cancer Institute, Boca Raton, Florida

Holy Cross Hospital - Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, Florida

Mayo Clinic Florida, Jacksonville, Florida

University of Miami, Miami, Florida

Piedmont Cancer Institute, Atlanta, Georgia

Winship Cancer Institute / Emory University School of Medicine, Atlanta, Georgia

University of Chicago Medical Center, Chicago, Illinois

Decatur Memorial Hospital - Illinois, Decatur, Illinois

Northwestern Medicine Cancer Center - Kishwaukee / Kishwaukee Cancer Center, DeKalb, Illinois

Northwestern Medicine Cancer Center Delnor, Geneva, Illinois

Cardinal Bernardin Cancer Center / Loyola University Medical Center, Maywood, Illinois

Northwestern Medicine Cancer Center - Warrenville / Central DuPage Hospital - Cancer Care, Warrenville, Illinois

University of Kansas Cancer Center, Westwood, Kansas

Tulane University Hospital and Clinic, New Orleans, Louisiana

Ochsner Clinic Foundation, New Orleans, Louisiana

Maryland Oncology Hematology, P.A., Silver Spring, Maryland

Southcoast Centers for Cancer Care - Fairhaven Site, Fairhaven, Massachusetts

University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan

Henry Ford Health System, Detroit, Michigan

McLaren Greater Lansing Hospital, Lansing, Michigan

University of Minnesota, Minneapolis, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Washington University School of Medicine - Siteman Cancer Center, Saint Louis, Missouri

Nebraska Hematology Oncology P.C., Lincoln, Nebraska

OptumCare Cancer Center, Las Vegas, Nevada

Memorial Sloan Kettering Cancer Center - Basking Ridge, Basking Ridge, New Jersey

Hackensack University Medical Center, Hackensack, New Jersey

Memorial Sloan Kettering Cancer Center - Monmouth, Middletown, New Jersey

Memorial Sloan Kettering Cancer Center - Bergen, Montvale, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

New York Oncology Hematology, P.C., Albany, New York

Roswell Park Cancer Institute, Buffalo, New York

Memorial Sloan Kettering Cancer Center - Commack, Commack, New York

Memorial Sloan Kettering Cancer Center - Westchester, Harrison, New York

Northwell Cancer Center / Monter Cancer Center, Lake Success, New York

NYU Winthrop Hospital, Mineola, New York

New York University (NYU) Cancer Institute, New York, New York

Weill Cornell Medical College, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Rochester Medical Center, Rochester, New York

Memorial Sloan Kettering Cancer Center - Nassau, Uniondale, New York

UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill, North Carolina

Levine Cancer Institute, Charlotte, North Carolina

Duke University Medical Center, Durham, North Carolina

Vidant Medical Center, Greenville, North Carolina

Gabrail Cancer Center Research, LLC, Canton, Ohio

Case Western Reserve University / University Hospitals Case Medical Center, Cleveland, Ohio

Toledo Clinic Cancer Center, Toledo, Ohio

CMOH Broomall, Broomall, Pennsylvania

Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania

Fox Chase Cancer Center, Philadelphia, Pennsylvania

Allegheny General Hospital, Pittsburgh, Pennsylvania

Medical University of South Carolina/Hollings Cancer Center, Charleston, South Carolina

Saint Francis Hospital Cancer Center, Greenville, South Carolina

Carolina Urologic Research Center, Myrtle Beach, South Carolina

Sarah Cannon Research Institute, Chattanooga, Tennessee

Tennessee Oncology / Sarah Cannon Research Institute, Nashville, Tennessee

Texas Oncology - Fort Worth Cancer Center, Fort Worth, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Texas Oncology - Tyler, Tyler, Texas

Utah Cancer Specialists, Salt Lake City, Utah

University of Virginia, Charlottesville, Virginia

Virginia Oncology Associates - Norfolk, Norfolk, Virginia

Medical Oncology Associates, Spokane, Washington

Medical College of Wisconsin (Milwaukee), Milwaukee, Wisconsin

Site CA11008, East Brampton, Ontario

Site CA11011, Kingston, Ontario

Site CA11001, Toronto, Ontario

Site CA11005, Montreal, Quebec

Site CA11013, Montreal, Quebec

Site CA11002, Sherbrooke, Quebec

Site FR33008, Bordeaux, Not set

Site FR33005, Dijon, Not set

Site FR33003, Lyon, Not set

Site FR33004, Marseilles, Not set

Site FR33010, Moselle, Not set

Site FR33002, Nice Cedex, Not set

Site FR33006, Pierre-Benite, Not set

Site FR33001, Strasbourg, Not set

Site IT39002, Terni, Not set

Site PR78701, Rio Piedras, Not set

Site ES34006, Barcelona, Not set

Site ES34008, Madrid, Not set

Site ES34001, Madrid, Not set

Site ES34012, Madrid, Not set

Site ES34007, Pamplona, Not set

Site ES34005, Sabadell, Not set

Site ES34004, Santander, Not set

Conditions: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Urologic Neoplasms, Renal Pelvis Neoplasms, Urothelial Cancer, Ureteral Neoplasms, Urethral Neoplasms

Learn More ›

Efficacy and Safety Study of First-line Treatment With Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Women With Persistent, Recurrent, or Metastatic Cervical Cancer (MK-3475-826/KEYNOTE-826)

NCT03635567

Completed

The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) plus one of four platinum-based chemotherapy regimens compared to the efficacy and safety of placebo plus one of four platinum-based chemotherapy regimens in the treatment of adult women with persistent, recurrent, or metastatic cervical cancer. Possible chemotherapy regimens include: paclitaxel plus cisplatin with or without bevacizumab and paclitaxel plus carboplatin with or without bevacizumab. The prim... Read More

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

04/29/2025

Locations: Alaska Women's Cancer Care ( Site 1770), Anchorage, Alaska +148 locations

Alaska Women's Cancer Care ( Site 1770), Anchorage, Alaska

Arizona Oncology Associates, PC- HAL ( Site 8005), Phoenix, Arizona

UC Irvine Health ( Site 1796), Orange, California

Smilow Cancer Hospital at Yale New Haven ( Site 1809), New Haven, Connecticut

H. Lee Moffitt Cancer Center and Research Institute ( Site 1754), Tampa, Florida

Georgia Cancer Center at Augusta University ( Site 1767), Augusta, Georgia

Barbara Ann Karmanos Cancer Institute ( Site 1785), Detroit, Michigan

Henry Ford Health System ( Site 1810), Detroit, Michigan

Washington University School of Medicine ( Site 1779), Saint Louis, Missouri

Cancer Institute of New Jersey at University Hospital ( Site 1762), Newark, New Jersey

Holy Name Medical Center ( Site 1776), Teaneck, New Jersey

Mount Sinai Chelsea ( Site 1760), New York, New York

Columbia University Medical Center ( Site 1800), New York, New York

OSU Wexner Medical Center ( Site 1817), Hilliard, Ohio

University of Oklahoma- Stephenson Oklahoma Cancer Center ( Site 1784), Oklahoma City, Oklahoma

Oklahoma Cancer Specialists and Research Institute, LLC ( Site 1768), Tulsa, Oklahoma

MUSC Hollings Cancer Center ( Site 1819), Charleston, South Carolina

West Cancer Center - East Campus ( Site 1763), Germantown, Tennessee

Texas Oncology-San Antonio Medical Center ( Site 8001), San Antonio, Texas

Seattle Cancer Care Alliance ( Site 1777), Seattle, Washington

Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1006), Berazategui, Buenos Aires

Hospital Aleman ( Site 1005), Buenos Aires, Not set

Hospital de Oncologia Angel Roffo ( Site 1003), Buenos Aires, Not set

Instituto Medico Especializado Alexander Fleming ( Site 1009), Buenos Aires, Not set

Centro Oncologico Riojano Integral ( Site 1004), La Rioja, Not set

Centro Medico San Roque ( Site 1001), Tucuman, Not set

Royal North Shore Hospital ( Site 1514), St Leonards, New South Wales

Mater Misericordiae Ltd Mater Cancer Care Centre ( Site 1521), South Brisbane, Queensland

Flinders Medical Centre ( Site 1513), Bedford Park, South Australia

St John of God Subiaco Hospital ( Site 1512), Subiaco, Western Australia

Monash Health-Monash Medical Centre ( Site 1519), Clayton, Not set

Tom Baker Cancer Centre ( Site 1728), Calgary, Alberta

BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 1734), Kelowna, British Columbia

BC Cancer - Vancouver Center ( Site 1722), Vancouver, British Columbia

CancerCare Manitoba ( Site 1725), Winnipeg, Manitoba

Queen Elizabeth II Health Sciences Centre ( Site 1731), Halifax, Nova Scotia

Juravinski Cancer Centre ( Site 1735), Hamilton, Ontario

London Regional Cancer Program - London HSC ( Site 1723), London, Ontario

The Ottawa Hospital Cancer Centre ( Site 1736), Ottawa, Ontario

Sunnybrook Research Institute ( Site 1733), Toronto, Ontario

Princess Margaret Cancer Centre ( Site 1732), Toronto, Ontario

CIUSSS du Saguenay-Lac-St-Jean ( Site 1729), Chicoutimi, Quebec

CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 1726), Montreal, Quebec

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1721), Montreal, Quebec

CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 1730), Sherbrooke, Quebec

CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 1724), Quebec, Not set

Oncocentro ( Site 1065), Vina del Mar, Valparaiso

Fundacion Arturo Lopez Perez FALP ( Site 1061), Santiago, Not set

Sociedad Oncovida S.A. ( Site 1069), Santiago, Not set

Centro de Cancer Nuestra Senora de la Esperanza ( Site 1063), Santiago, Not set

Instituto Clinico Oncologico del Sur ( Site 1062), Temuco, Not set

Sociedad de Oncologia y Hematologia del Cesar Ltda. ( Site 1103), Valledupar, Cesar

Instituto Nacional de Cancerologia E.S.E ( Site 1095), Bogota, Cundinamarca

Hemato Oncologos S.A. ( Site 1100), Cali, Valle

Biomelab S A S ( Site 1104), Barranquilla, Not set

Oncomedica S.A. ( Site 1098), Monteria, Not set

Instituto Cancerologico de Narino Ltda ( Site 1097), Pasto, Not set

Centre Jean Perrin ( Site 1181), Clermont Ferrand, Not set

Institut Paoli Calmettes ( Site 1182), Marseille, Not set

Groupe Hospitalier Broca Cochin Hotel Dieu ( Site 1183), Paris, Not set

Centre Eugene Marquis ( Site 1187), Rennes, Not set

Institut Curie - Centre Rene Huguenin ( Site 1185), Saint-Cloud, Not set

Universitaetsklinikum Carl Gustav Carus ( Site 1211), Dresden, Not set

Universitaetsklinikum Duesseldorf ( Site 1220), Duesseldorf, Not set

Universitatsklinikum Essen AoR ( Site 1213), Essen, Not set

Universitatsklinikum Hamburg-Eppendorf ( Site 1212), Hamburg, Not set

Gynoncological Practice Lueck. Schrader. Noeding ( Site 1224), Hannover, Not set

Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 1214), Kiel, Not set

Rotkreuzklinikum Muenchen gGmbH. Studienzentrale Frauenklinik ( Site 1225), Muenchen, Not set

Klinikum Oldenburg AoeR ( Site 1218), Oldenburg, Not set

Universitaet Regensburg ( Site 1221), Regensburg, Not set

Soroka Medical Center ( Site 1363), Beer-Sheva, Not set

Rambam Medical Center ( Site 1364), Haifa, Not set

Shaare Zedek Medical Center ( Site 1366), Jerusalem, Not set

Hadassah Medical Center. Ein Kerem ( Site 1367), Jerusalem, Not set

Rabin Medical Center ( Site 1365), Petah Tikva, Not set

Chaim Sheba Medical Center ( Site 1361), Ramat Gan, Not set

Sourasky Medical Center ( Site 1362), Tel Aviv, Not set

Centro di Riferimento Oncologico de Aviano Istituto Nazionale Tumori ( Site 1243), Aviano, Not set

A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1245), Bolgna, Not set

Istituto Nazionale Tumori ( Site 1251), Milano, Not set

Istituto Europeo di Oncologia ( Site 1250), Milano, Not set

Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1242), Napoli, Not set

Policlinico Universitario -Agostino Gemelli ( Site 1241), Roma, Not set

The Jikei University Kashiwa Hospital ( Site 1701), Kashiwa, Chiba

National Cancer Center Hospital East ( Site 1704), Kashiwa, Chiba

Ehime University Hospital ( Site 1693), Toon, Ehime

Kurume University Hospital ( Site 1692), Kurume, Fukuoka

National Hospital Organization Hokkaido Cancer Center ( Site 1700), Sapporo, Hokkaido

Hyogo Cancer Center ( Site 1705), Akashi, Hyogo

Iwate Medical University Hospital ( Site 1695), Shiwa-gun, Iwate

University of the Ryukyus Hospital ( Site 1706), Nakagami-gun, Okinawa

Saitama Medical University International Medical Center ( Site 1691), Hidaka, Saitama

Shizuoka Cancer Center Hospital and Research Institute ( Site 1703), Sunto-gun, Shizuoka

National Cancer Center Hospital ( Site 1702), Tokyo, Not set

The Jikei University Hospital ( Site 1697), Tokyo, Not set

The Cancer Institute Hospital of JFCR ( Site 1698), Tokyo, Not set

Keio University Hospital ( Site 1699), Tokyo, Not set

Keimyung University Dongsan Medical Center ( Site 1603), Daegu, Not set

Seoul National University Hospital ( Site 1602), Seoul, Not set

Asan Medical Center ( Site 1601), Seoul, Not set

Samsung Medical Center ( Site 1604), Seoul, Not set

Medical Care and Research S.A. de C.V. ( Site 1135), Merida, Yucatan

Centro Estatal de Cancerologia de Chihuahua ( Site 1123), Chihuahua, Not set

Consultorio de Medicina Especializada del Sector Privado ( Site 1129), Ciudad de Mexico, Not set

CRYPTEX Investigacion Clinica S.A. de C.V. ( Site 1127), Ciudad de Mexico, Not set

Instituto Nacional de Cancerologia. ( Site 1130), Mexico, Not set

Centro de Urologia Avanzada del Noreste S.A. de C.V. ( Site 1125), San Pedro Garza Garcia, Not set

Faicic S de RL de CV ( Site 1133), Veracruz, Not set

Hospital de Alta Complejidad de La Libertad Virgen de La Puerta ( Site 1152), Trujillo, La Libertad

Centro Medico Monte Carmelo ( Site 1156), Arequipa, Not set

Hospital Nacional Guillermo Almenara Irigoyen ( Site 1158), Lima, Not set

Instituto de Oncologia y Radioterapia Clinica Ricardo Palma ( Site 1157), Lima, Not set

Instituto Nacional de Enfermedades Neoplasicas ( Site 1153), Lima, Not set

Hospital Nacional Arzobispo Loayza ( Site 1159), Lima, Not set

Hospital Nacional Maria Auxiliadora ( Site 1155), Lima, Not set

Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1331), Kazan, Not set

FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1334), Moscow, Not set

Medical Rehabilitation Center ( Site 1337), Moscow, Not set

Novosibirsk Regional Clinical Oncology Dispensary ( Site 1358), Novosibirsk, Not set

Municipal Clinical Oncology Center ( Site 1346), Saint Petersburg, Not set

National Research Ogarev Mordovia State University ( Site 1347), Saransk, Not set

National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 1348), St. Petersburg, Not set

Tomsk Scientific Research Institute of Oncology ( Site 1360), Tomsk, Not set

Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1345), Ufa, Not set

Onkologikoa - Instituto Oncologico de San Sebastian ( Site 1275), Doniostia - San Sebastian, Guipuzcoa

Hospital Quiron Madrid ( Site 1277), Pozuelo de Alarcon, Madrid

Hospital Germans Trias i Pujol. ICO de Badalona ( Site 1276), Badalona, Not set

MD Anderson Cancer Center Madrid ( Site 1273), Madrid, Not set

Hospital Universitario Virgen Macarena ( Site 1274), Sevilla, Not set

Kaohsiung Veterans General Hospital ( Site 1632), Kaohsiung, Not set

China Medical University Hospital ( Site 1635), Taichung, Not set

Taichung Veterans General Hospital ( Site 1634), Taichung, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 1636), Taipei, Not set

Taipei Veterans General Hospital ( Site 1631), Taipei, Not set

Chang Gung Medical Foundation. Linkou ( Site 1633), Taoyuan, Not set

Baskent Adana Dr Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 1457), Adana, Not set

Hacettepe University Medical Faculty ( Site 1459), Ankara, Not set

Baskent Universitesi Ankara Hastanesi ( Site 1451), Ankara, Not set

Akdeniz Universitesi Tip Fakultesi ( Site 1453), Antalya, Not set

Medeniyet University Goztepe Egitim ve Arastırma Hast. Merdivenkoy ( Site 1458), Istanbul, Not set

Ege University Medical Faculty Tulay Aktas Oncology Hospital ( Site 1456), Izmir, Not set

Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi ( Site 1452), Konya, Not set

City Clinical Hosp.4 of DCC ( Site 1482), Dnipropetrovsk, Not set

MI Precarpathian Clinical Oncology Center ( Site 1487), Ivano-Frankivsk, Not set

Communal non profit enterprise Regional Clinical Oncology Center ( Site 1489), Kharkiv, Not set

National Cancer Institute of the MoH of Ukraine ( Site 1484), Kyiv, Not set

MI Odessa Regional Oncological Centre ( Site 1493), Odesa, Not set

Medical Centre LLC Oncolife ( Site 1485), Zaporizhzhya, Not set

Conditions: Cervical Cancer

Learn More ›

TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

NCT04129502

Active Not Recruiting

The purpose of this study is to compare effectiveness of TAK-788 as first-line treatment with that of platinum-based chemotherapy in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors has epidermal growth factor receptor (EGFR) exon 20 insertion mutations. Participants will be randomly assigned to one of the two treatment groups- TAK-788 group or Platinum-based chemotherapy group. Participants will receive TAK-788 orally and pemetrexed/cisplatin or... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/21/2025

Locations: City of Hope National Medical Center, Long Beach, California +133 locations

City of Hope National Medical Center, Long Beach, California

University of California Irvine, Orange, California

Stanford University, Palo Alto, California

AdventHealth, Orlando, Florida

Northwestern University, Chicago, Illinois

University of Maryland Greenebaum Cancer Center, Baltimore, Maryland

Beth Israel Deaconess Medical Center - 330 Brookline Ave, Boston, Massachusetts

Dana Farber Cancer Institute, Boston, Massachusetts

Massachusetts General Hospital, Boston, Massachusetts

Sarah Cannon Cancer Center, Nashville, Tennessee

University of Virginia Health System, Charlottesville, Virginia

GenesisCare North Shore, St Leonards, New South Wales

Princess Alexandra Hospital, Woolloongabba, Queensland

Flinders Medical Centre, Bedford Park, South Australia

Klinik Floridsdorf, Wien, Not set

Cliniques Universitaires Saint-Luc, Bruxelles, Brussels

Grand Hopital de Charleroi asbl, Charleroi, Hainaut

AZ Sint-Lucas, Aalst, Oost-Vlaanderen

British Columbia Cancer Agency, Vancouver, British Columbia

William Osler Health System, Brampton, Ontario

Princess Margaret Hospital, Toronto, Ontario

Hopital Du Sacre Coeur de Montreal, Montreal, Quebec

Beijing Cancer Hospital - PPDS, Beijing, Beijing

Henan Cancer Hospital, Zhengzhou, Henan

Jilin Cancer Hospital, Changchun, Jilin

Beijing Cancer Hospital - PPDS, Beijing, Not set

Beijing Chest Hospital, Capital Medical Univerity, Beijing, Not set

Icahn School of Medicine at Mount Sinai, Beijing, Not set

Sichuan Cancer Hospital & Institute, Chengdu, Not set

Guangdong Provincial People's Hospital, Guangzhou, Not set

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Not set

Harbin Medical University Tumor Hospital, Harbin, Not set

Shanghai East Hospital, Shanghai, Not set

Hubei Cancer Hospital, Wuhan, Not set

Centre Francois Baclesse, Caen, Calvados

CHU de Nantes - Hoptal Nord Laennec, Nantes, Loire-Atlantique

Hopital Calmette, Lille, Nord

Centre Leon Berard, Lyon, Rhone

Institut Gustave Roussy, Villejuif, Val-de-Marne

CHU de Grenoble, Grenoble, Not set

Hopital Nord AP-HM, Marseille, Not set

CRLC Val d'Aurelle - Paul Lamarque, Montpellier, Not set

Hopital Tenon, Paris, Not set

Nouvel Hopital Civil, Strasbourg, Not set

Hopital Larrey, Toulouse, Not set

Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg

LMU Klinikum der Universitat Munchen, Munchen, Bayern

University Clinic Regensburg, Regensburg, Bayern

Universitatsklinikum Frankfurt, Frankfurt am Main, Hessen

Pius Hospital Oldenburg, Oldenburg, Niedersachsen

Helios Klinikum Emil Von Behring, Berlin, Not set

Sotiria Chest Hospital of Athens, Athens, Attiki

Bioclinic Thessaloniki (Galinos clinic), Thessaloniki, Not set

Princess Margaret Hospital, Kowloon, Kowloon City

Pamela Youde Nethersole Eastern Hospital, Hong Kong, Not set

Queen Elizabeth Hospital (QEH), Hong Kong, Not set

Queen Mary Hospital - PPDS, Hong Kong, Not set

Tuen Mun Hospital, Hong Kong, Not set

Prince of Wales Hospital, Sha Tin, Not set

Soroka University Medical Centre, Beer Sheva, Not set

Sheba Medical Center - PPDS, Ramat Gan, Not set

AORN Dei Colli- Ospedale Monaldi Napoli, Napoli, Campania

Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l - PPDS, Meldola, Forli-Cesena

Istituto Nazionale Dei Tumori, Milano, Lombardia

Instituto Europeo Di Oncologia, Milano, Lombardia

Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano, Piemonte

Centro Di Riferimento Oncologico, Aviano, Pordenone

Azienda Ospedaliero Universitaria Pisana, Pisa, Toscana

Azienda Ospedaliero Universitaria di Parma, Parma, Not set

Ospedale Santa Maria Delle Croci, Ravenna, Not set

Fujita Health University Hospital, Toyoake-Shi, Aiti

Ehime University Hospital, Matsuyama-Shi, Ehime

National Hospital Organization Hokkaido Cancer Center, Sapporo-Shi, Hokkaido

Kurume University Hospital, Kurume-Shi, Hukuoka

Kanagawa Cancer Center, Yokohama-Shi, Kanagawa

Saiseikai Kumamoto Hospital, Kumamoto-Shi, Kumamoto

Miyagi Cancer Center, Natori-Shi, Miyagi

Okayama University Hospital, Okayama-Shi, Okayama

Osaka International Cancer Institute, Chuo Ku, Osaka

Saitama Cancer Center, Komoro, Saitama

National Cancer Center Hospital East, Kashiwa-Shi, Tiba

The Cancer Institute Hospital of Japanese Foundation For Cancer Research, Koto-Ku, Tokyo

Chungbuk National University Hospital, Cheongju-si, Chungcheongbugdo

Pusan National University Hospital, Busan, Not set

National Cancer Center, Goyang, Not set

Chonnam National University Hwasun Hospital, Jeongnam, Not set

Seoul National University Hospital, Seoul, Not set

Asan Medical Center - PPDS, Seoul, Not set

Samsung Medical Center PPDS, Seoul, Not set

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul, Not set

Severance Hospital Yonsei University Health System - PPDS, Seoul, Not set

VU Medisch Centrum, Amsterdam, Noord-Holland

Centro Hospitalar do Porto Hospital de Santo Antonio, Santa Maria Da Feira, Aveiro

Hospital Cuf Porto, Vila Nova de Gaia, Porto

Centro Hospitalar de Lisboa Norte E.P.E Hospital Pulido Valente, Lisboa, Not set

Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto, Not set

Centro Hospitalar de Sao Joao, E.P.E., Porto, Not set

GBUZ Saint Petersburg Clinical Research Center of Specialized Types of Care (Oncology), Saint Petersburg, Leningradskaya Oblast

LLC "EuroCityClinic", Saint Petersburg, Sankt-Peterburg

National Cancer Centre, Singapore, Not set

ICO lHospitalet Hospital Duran i Reynals, L'Hospitalet de Llobregat, Barcelona

Hospital Universitario A Coruna, A Coruna, Not set

Hospital General Universitario de Alicante, Alicante, Not set

Hospital Universitario Vall d'Hebron - PPDS, Barcelona, Not set

Hospital Clinic de Barcelona, Barcelona, Not set

C.H. Regional Reina Sofia - PPDS, Cordoba, Not set

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Paz - PPDS, Madrid, Not set

Hospital Universitari i Politecnic La Fe de Valencia, Valencia, Not set

Karolinska Universitetssjukhuset Solna, Stockholm, Sodermanlands Lan

Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Dalin, Not set

National Taiwan University Hospital - YunLin Branch, Douliu, Not set

Kaohsiung Medical University - Chung-Ho Memorial Hospital, Kaohsiung, Not set

E-DA hospital, Kaohsiung, Not set

Taichung Veterans General Hospital, Taichung City, Not set

Chi Mei Medical Center, Liouying, Tainan City, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Baskent University Medical Faculty Adana Practice and Research Center, Yuregir, Adana

T.C. Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Kadikoy, Istanbul

Ege University Medical Faculty, Bornova, Izmir

SAKARYA University Medical Faculty, Karaman, Sakarya

Hacettepe University Medical Faculty, Ankara, Not set

Trakya University Medical Faculty, Edirne, Not set

Municipal Non-profit Enterprise "City Clinical Hospital # 4" of Dnipro City Council - PPDS, Dnipropetrovsk, Dnipropetrovs'ka Oblast

Communal Non-profit Enterprise Regional Center of Oncology, Kharkiv, Kharkivs'ka Oblast

Private Enterprise Private Manufacturing Company Acinus, Kropyvnytskyi, Not set

University College London Hospitals (UCLH), London, London, City Of

Royal Marsden Hospital - Surrey, Sutton, Surrey

Clatterbridge Centre For Oncology, Bebington, Wirral

Leicester General Hospital, Leicester, Not set

The Christie NHS Foundation Trust - PPDS, Manchester, Not set

Conditions: Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Learn More ›

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

NCT04194944

Active Not Recruiting

The reason for this study is to see if the study drug selpercatinib compared to a standard treatment is effective and safe in participants with rearranged during transfection (RET) fusion-positive non-squamous non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Participants who are assigned to the standard treatment and discontinue due to progressive disease have the option to potentially crossover to selpercatinib.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: Centro de Oncología e Investigación de Buenos Aires, Berazategui, Buenos Aires +195 locations

Centro de Oncología e Investigación de Buenos Aires, Berazategui, Buenos Aires

Fundacion CENIT para la Investigacion en Neurociencias, Caba, Buenos Aires

Clinica Viedma, Viedma, Río Negro

Alexander Fleming, Ciudad de Buenos Aires, Not set

Clínica El Castaño, San Juan, Not set

Chris O'Brien Lifehouse, Camperdown, New South Wales

Calvary Mater Newcastle, Waratah, New South Wales

Westmead Hospital, Westmead, New South Wales

Monash Health, Clayton, Victoria

Peter MacCallum Cancer Centre, Melbourne, Victoria

St Vincent's Hospital, Melbourne, Victoria

Peninsula Oncology Centre, Frankston, Not set

UZ Brussel, Brussels, Bruxelles-Capitale, Région De

AZ Nikolaas, Sint Niklaas, Oost-Vlaanderen

UZ Leuven, Leuven, Vlaams-Brabant

AZ Delta, Roeselare, West Flanders

UZ Gent Hospital, Gent, Not set

AZ Sint-Maarten, Campus Leopoldstraat 2, Mechelen, Not set

CHU UCL Namur/Site Sainte Elisabeth, Namur, Not set

Núcleo de Oncologia da Bahia, Salvador, Bahia

Hospital de Cancer de Londrina, Londrina, Paraná

Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul

Grupo COI - Clínicas Oncológicas Integradas, Rio de Janeiro, RJ

Fundação Pio XII - Hospital de Câncer de Barretos, Barretos, Sao Paulo

Instituto D'Or de Pesquisa e Ensino (IDOR), Sao Paulo, SP

Instituto Nacional de Câncer - INCA, Rio de Janeiro, Not set

Centro de Tratamento de Tumores Botafogo para Oncoclinicas Rio de Janeiro SA, Rio de Janeiro, Not set

Hospital Sírio Libanês, Sao Paolo, Not set

Icesp - Instituto Do Câncer Do Estado de São Paulo, Sao Paulo, Not set

Hospital Sírio Libanês, São Paulo, Not set

Cross Cancer Institute, Edmonton, Alberta

Princess Margaret Cancer Centre, Toronto, Ontario

Beijing Cancer hospital, Beijing, Beijing

First affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong

The First Affiated Hospital Of Guangzhou Medical Collage, Guangzhou, Guangzhou

Harbin Medical University Cancer Hospital, Harbin, Heilongjiang

Wuhan Union Hospital, Wuhan, Hubei

Hunan Provincial People's Hospital, Changsha, Hunan

Hunan Cancer Hospital, Changsha, Hunan

Changzhou No.2 People's Hospital, Changzhou, Jiangsu

Jilin Cancer Hospital, Changchun, Jilin

Shanghai Pulmonary Hospital, Shanghai, Shanghai

West China Hospital of Sichuan University, Cheng Du, Sichuan

Xinjiang Medical University Cancer Hospital - Urumqi, Urumqi, Xinjiang

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

First Affiliated Hosp of College of Med, Zhejiang University, Hangzhou, Not set

Shanghai Chest Hospital, Shanghai, Not set

Fakultni nemocnice Olomouc, Olomouc, Not set

Nemocnice AGEL Ostrava - Vitkovice a.s., Ostrava - Vitkovice, Not set

Fakultni nemocnice Bulovka, Praha 8, Not set

Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone, Marseille, Bouches-du-Rhône

Institut Régional du Cancer Montpellier, Montpellier Cedex 5, Hérault

Chu Grenoble Alpes, La Tronche, Isère

Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne, Clermont-Ferrand, Puy-de-Dôme

Centre Leon Berard, Lyon, Rhône-Alpes

Hopitaux Universitaires Paris Centre-Hopital Cochin, Paris, Not set

Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Württemberg

Asklepios Fachkliniken München-Gauting, Gauting, Bayern

Klinikverbund Kempten-Oberallgäu, Immenstadt, Bayern

Franziskus-Hospital Harderberg, Georgsmarienhütte, Niedersachsen

Universitätsmedizin Göttingen, Göttingen, Niedersachsen

University Hospital of Cologne, Köln, Nordrhein-Westfalen

LungenClinic Grosshansdorf, Grosshansdorf, Schleswig-Holstein

Charite Universitätsmedizin Berlin Campus Benjamin Franklin, Berlin, Not set

Sotiria Thoracic Diseases Hospital of Athens, Athens, Attikí

University General Hospital of Heraklion, Heraklion, Krítí

European Interbalkan Medical Center, Thessaloniki, Thessaloníki

G. Papanikolaou General Hospital, Thessaloniki, Thessaloníki

Hong Kong United Oncology Centre, Jordan, Kowloon

Prince of Wales Hospital, Shatin, Not set

Soroka Medical Center, Beer-Sheva, Not set

Shaare Zedek Medical Center, Jerusalem, Not set

Hadassah Medical Center, Jerusalem, Not set

Sheba Medical Center, Ramat Gan, Not set

Rambam Health Care Campus, Haifa, Ḥeifā

Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania

Ospedale Santa Maria delle Croci, Ravenna, Emilia-Romagna

Cro-Irccs, Aviano, Friuli-Venezia Giulia

Azienda Ospedaliera San Camillo Forlanini, Roma, Lazio

Fondazione Policlinico Universitario Agostino Gemelli, Roma, Lazio

Ospedale San Gerardo-ASST Monza, Monza, Lombardia

ASST Grande Ospedale Metropolitano Niguarda, Milan, Milano

Humanitas, Rozzano, Milano

Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano, Torino

Azienda Ospedaliera San Giuseppe Moscati, Avellino, Not set

IRCCS - AOU di Bologna, Bologna, Not set

Azienda Ospedaliera Universitaria Pisana, Pisa, Not set

Istituto Nazionale Tumori Regina Elena, Roma, Not set

National Cancer Center Hospital East, Kashiwa, Chiba

National Hospital Organization Hokkaido Cancer Center, Sapporo, Hokkaido

Kanazawa University Hospital, Kanazawa, Ishikawa

Kanagawa cancer center, Yokohama, Kanagawa

Kindai University Hospital- Osakasayama Campus, Osaka Sayama-shi, Osaka

Tominaga Hospital, Nagaizumi, Shizuoka

National Cancer Center Hospital, Chuo-ku, Tokyo

Japanese Foundation for Cancer Research, Koto, Tokyo

Tottori University Hospital, Yonago, Tottori

Okayama University Hospital, Okayama, Not set

Osaka International Cancer Institute, Osaka, Not set

National Cancer Center, Goyang-si, Gyeonggi-do

Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do

Gachon University Gil Medical Center, Incheon, Korea

Asan Medical Center, Seoul, Korea

Gyeongsang National University Hospital, Jin-ju-si, Kyǒngsangnam-do

Seoul National University Hospital, Seoul, Seoul, Korea

Boramae Medical Center, Dongjak-gu, Seoul-teukbyeolsi [Seoul]

Konyang University Hospital, Daejon, Not set

Samsung Medical Center, Seoul, Not set

Health Pharma Professional Research S.A. de C.V:, Mexico City, Federal District

Actualidad Basada en la Investigación del Cáncer, Guadalajara, Jalisco

Oncologico Potosino, S.C., San Luis Potosí, Not set

Ziekenhuis St. Jansdal, Harderwijk, Gelderland

Jeroen Bosch Hospital, Den Bosch, Noord-Brabant

Erasmus Medisch Centrum, Rotterdam, Zuid-Holland

Amsterdam UMC, locatie VUmc, Amsterdam, Not set

Uniwersyteckie Centrum Kliniczne, Gdansk, Not set

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy, Warszawa, Not set

Institutul Oncologic, Bucharest, București

Gral Medical Diagnostic Center, Bucuresti, București

Constanta County Emergency Clinical Hospital Sf.Ap.Andrei, Constanta, Constanța

Cabinet Medical Oncomed, Timișoara, Timiș

Spitalul Universitar de Urgență București, Bucuresti, Not set

Institutul Oncologic, Cluj-Napoca, Not set

Spitalul Județean Sfântul Ioan cel Nou Suceava, Suceava, Not set

GBUZ Republican Clinical Oncological Dispensary, Ufa, Baškortostan, Respublika

Kaluga Regional Clinical Oncology Center, Kaluga, Kalužskaja Oblast

Murmansk Regional Clinical Hospital P.A. Bayandina, Murmansk, Murmanskaya Oblast'

Samara Regional Clinical Oncology Center, Samara, Samarskaya Oblast'

Scientific research institution of oncology named after N.N. Petrov, Saint Petersburg, Sankt-Peterburg

Saint-Petersburg Scientific-Practical Center of Specialized Kinds of Medical Care (oncological) named afte -T, St. Petersburg, Sankt-Peterburg

Arkhangelsk Clinical Oncological Dispensary, Arkhangelsk, Not set

Republican Clinical Oncology Dispensary, Kazan, Not set

First Moscow State Medical University I.M. Sechenov, Moscow, Not set

Hadassah Medical, Moscow, Not set

Tan Tock Seng Hospital, Singapore, Not set

Hospital Fundacion Son Llatzer, Palma de Mallorca, Baleares

Institut Català d'Oncologia (ICO) - Badalona, Badalona, Barcelona [Barcelona]

CHUS - Hospital Clinico Universitario, Santiago de Compostela, Galicia [Galicia]

Hospital Insular de Gran Canaria, Las palmas de gran canaria, Las Palmas

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid

Clinica Universitaria De Navarra, Pamplona, Navarra

Hospital General Universitario de Alicante, Alicante, Not set

Parc de Salut Mar - Hospital del Mar, Barcelona, Not set

Hospital Universitari Dexeus, Barcelona, Not set

Instituto Catalan de Oncologia - Hospital Duran i Reynals, Barcelona, Not set

Hospital de la Santa Creu i Sant Pau, Barcelona, Not set

Complejo Hospitalario de Jaén, Jaén, Not set

Clinica Universidad de Navarra, Madrid, Not set

Hospital Universitario Ramón y Cajal, Madrid, Not set

Hospital Clinico San Carlos, Madrid, Not set

Hospital Universitario 12 de Octubre, Madrid, Not set

Hospital Universitario La Paz, Madrid, Not set

Hospital Regional Universitario, Malaga, Not set

Complejo Hospitalario de Navarra, Pamplona, Not set

Hospital Universitario Virgen Macarena, Sevilla, Not set

Hospital Universitario Virgen Del Rocio, Sevilla, Not set

Hospital Clínico Universitario de Valencia, Valencia, Not set

Hospital Universitari i Politecnic La Fe, Valencia, Not set

Changhua Christian Hospital, Changhua County, Changhua

Buddhist Dalin Tzu Chi General Hospital, Dalin Town, Chiayi

Chang Gung Memorial Hospital - Linkou, Guei Shan Township, Taoyuan County

E-Da hospital, Kaohsiung, Not set

Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung, Not set

Tri-Service General Hospital, Neihu Taipei, Not set

Taipei Medical University Shuang Ho Hospital, New Taipei, Not set

Chung Shan Medical University Hospital, Taichung, Not set

China Medical University Hospital, Taichung, Not set

Taichung Veterans General Hospital, Taichung, Not set

Chi Mei Hospital - Liouying Branch, Tainan City, Not set

National Cheng-Kung Uni. Hosp., Tainan, Not set

National Taiwan University Hospital, Taipei City, Not set

Taipei Veterans General Hospital, Taipei, Not set

Ege Universitesi Hastanesi, Bornova, İzmir

Baskent University Dr. Turgut Noyan Research and Training Center, Adana, Not set

Abdurrahman Yurtaslan Ankara Oncology, education and Research Hospital, Ankara, Not set

Hacettepe University Faculty of Medicine, Ankara, Not set

Memorial Antalya Hastanesi, Antalya, Not set

Dicle Üniversitesi, Diyarbakir, Not set

Trakya University, Edirne, Not set

Istanbul Medeniyet University, Istanbul, Not set

zmir Katip Çelebi Üniversitesi Atatürk Eitim Ve Aratrma Hastanesi, Izmir, Not set

Izmir Medical Park Hospital, Izmir, Not set

Inonu Universitesi Turgut Ozal Tıp Merkezi, Malatya, Not set

Acıbadem Maslak Hastanesi, Sarıyer, Not set

Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, "Dnipro State Medical University", Dnipro, Dnipropetrovska Oblast

CNPE "Regional Center of Oncology", Kharkiv, Kharkivska Oblast

Odessa Regional Oncology Center, Odesa, Odeska Oblast

Sumy regional clinical oncological dispensary, Sumy, Sumska Oblast

Communal Noncommercial Enterprise "Podillia Regional Oncology Center Of Vinnytsia Regional Council", Vinnytsia, Vinnytska Oblast

Municipal Enterprise "Volyn Regional Medical Oncology Centre" of the Volyn Regional Council, Lutsk, Volynska Oblast

"Oncolife" LLC, Zaporizhya, Zaporizka Oblast

Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center", Chernivtsi, Not set

Medical Center "Mriya Med-Service", LLC, Kryvyi Rig, Not set

Municipal non-profit enterprise "Kyiv City Clinical Oncology Center" of executive body of Kyiv City Counci -T, Kyiv, Not set

Municipal non-profit enterprise'Odesa Regional Clinical Hospital'of Odesa Regional Council, Odesa, Not set

City Hospital, Nottingham University Hospitals, Nottingham, Nottinghamshire

Conditions: Non-Small Cell Lung Cancer

Learn More ›

A Study of LY3200882 in Participants With Solid Tumors

NCT02937272

Active Not Recruiting

The main purpose of this study is to evaluate the safety of the study drug known as LY3200882 in participants with solid tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/17/2025

Locations: University of Louisville, Louisville, Kentucky +17 locations

Conditions: Solid Tumor

Learn More ›

Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)

NCT04003636

Completed

This is a study of pembrolizumab plus gemcitabine/cisplatin versus placebo plus gemcitabine/cisplatin as first-line therapy in participants with advanced and/or unresectable biliary tract carcinoma. The primary hypothesis is pembrolizumab plus gemcitabine/cisplatin is superior to placebo plus gemcitabine/cisplatin with respect to overall survival (OS).

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/16/2025

Locations: University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016), Birmingham, Alabama +184 locations

University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016), Birmingham, Alabama

University of California San Diego Moores Cancer Center ( Site 0008), La Jolla, California

UCLA Hematology/Oncology - Santa Monica ( Site 0014), Los Angeles, California

University of California - San Francisco ( Site 0030), San Francisco, California

University of Colorado Hospital ( Site 0011), Aurora, Colorado

Hartford Hospital ( Site 0057), Hartford, Connecticut

Yale University ( Site 0053), New Haven, Connecticut

Winship Cancer Institute of Emory University ( Site 0013), Atlanta, Georgia

Northwest Georgia Oncology Centers PC ( Site 0045), Marietta, Georgia

Decatur Memorial Hospital ( Site 0056), Decatur, Illinois

Winthrop University Hospital ( Site 0059), Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0038), New York, New York

Columbia University/Herbert Irving Cancer Center ( Site 0009), New York, New York

University of Oklahoma- Stephenson Oklahoma Cancer Center ( Site 0055), Oklahoma City, Oklahoma

OHSU Center for Health & Healing ( Site 0044), Portland, Oregon

Charleston Oncology ( Site 0042), Charleston, South Carolina

Saint Francis Health System ( Site 0051), Greenville, South Carolina

Blue Ridge Cancer Care ( Site 0033), Roanoke, Virginia

CEMIC ( Site 0581), Buenos Aires, Caba

Fundacion Favaloro ( Site 0578), Ciudad de Buenos Aires, Caba

Centro Medico San Roque ( Site 0579), San Miguel de Tucuman, Tucuman

Hospital Municipal de Gastroenterologia Dr. Bonorino Udaondo ( Site 0580), Caba, Not set

Centro Oncologico Riojano Integral ( Site 0584), La Rioja, Not set

Liverpool Hospital ( Site 0707), Liverpool, New South Wales

Mid North Coast Cancer Institute ( Site 0708), Port Macquarie, New South Wales

Gallipoli Medical Research Foundation ( Site 0705), Brisbane, Queensland

Eastern Health ( Site 0704), Box Hill, Victoria

Western Health-Sunshine Hospital ( Site 0709), St Albans, Victoria

UZA University Hospital Antwerp ( Site 0202), Edegem, Antwerpen

Saint-Luc UCL ( Site 0200), Brussels, Bruxelles-Capitale, Region De

Erasme Hospital ( Site 0204), Bruxelles, Bruxelles-Capitale, Region De

Grand Hopital de Charleroi ( Site 0206), Charleroi, Hainaut

CHU de Liege ( Site 0201), Liège, Liege

UZ Gent ( Site 0203), Gent, Oost-Vlaanderen

UZ Leuven ( Site 0205), Leuven, Vlaams-Brabant

Oncobio Servicos de Saude SA ( Site 0604), Nova Lima, Minas Gerais

Hospital de Caridade de Ijui ( Site 0602), Ijui, Rio Grande Do Sul

Associacao Hospitalar Moinhos de Vento ( Site 0599), Porto Alegre, Rio Grande Do Sul

Hospital de Clinicas de Porto Alegre ( Site 0610), Porto Alegre, Rio Grande Do Sul

Hospital Nossa Senhora da Conceicao ( Site 0601), Porto Alegre, Rio Grande Do Sul

Instituto COI de Pesquisa Educacao e Gestao ( Site 0606), Rio de Janeiro, Not set

Instituto do Cancer do Estado de Sao Paulo - ICESP ( Site 0607), Sao Paulo, Not set

Hospital Paulistano - Amil Clinical Research ( Site 0603), Sao Paulo, Not set

Real e Benemerita Associacao Portuguesa de Beneficencia ( Site 0609), Sao Paulo, Not set

A.C. Camargo Cancer Center ( Site 0600), Sao Paulo, Not set

Tom Baker Cancer Centre ( Site 0184), Calgary, Alberta

Cross Cancer Institute ( Site 0183), Edmonton, Alberta

Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0182), Hamilton, Ontario

Centre Hospitalier de l Universite de Montreal - CHUM ( Site 0180), Montreal, Quebec

McGill University Health Centre ( Site 0179), Montreal, Quebec

Centro Investigación del Cáncer James Lind ( Site 0622), Temuco, Araucania

IC La Serena Research ( Site 0630), La Serena, Coquimbo

Servicios Medicos Urumed ( Site 0621), Rancagua, Lbtdr Gen Bernardo O Higgins

Fundacion Arturo Lopez Perez FALP ( Site 0623), Santiago, Region M. De Santiago

Sociedad Oncovida S.A. ( Site 0626), Santiago, Region M. De Santiago

Pontificia Universidad Catolica de Chile ( Site 0620), Santiago, Region M. De Santiago

Anhui Provincial Hospital ( Site 0140), Hefei, Anhui

Beijing Cancer Hospital ( Site 0138), Beijing, Beijing

Peking Union Medical College Hospital ( Site 0150), Beijing, Beijing

First Affiliated Hospital of The Third Military Medical University ( Site 0130), Chongqing, Chongqing

Fujian Provincial Cancer Hospital ( Site 0154), Fuzhou, Fujian

900 Hospital of the Joint ( Site 0137), Fuzhou, Fujian

Guangdong Provincial People s Hospital ( Site 0161), Guangzhou, Guangdong

The Third Xiangya Hospital of Central South University ( Site 0157), Changsha, Hainan

Harbin Medical University Cancer Hospital ( Site 0133), Harbin, Heilongjiang

Hunan Provincial People Hospital ( Site 0142), Changsha, Hunan

Hunan Cancer Hospital ( Site 0132), Changsha, Hunan

The 81st Hospital of PLA ( Site 0128), Nanjing, Jiangsu

The First Hospital of Jilin University ( Site 0131), Chanchun, Jilin

Zhongshan Hospital Fudan University ( Site 0129), Shanghai, Shanghai

Renji Hospital Shanghai Jiaotong University School of Medicine ( Site 0158), Shanghai, Shanghai

Fudan University Shanghai Cancer Center ( Site 0160), Shanghai, Shanghai

Tangdu Hospital ( Site 0146), XI An, Shanxi

The First Affiliated Hospital of Xi an Jiaotong University ( Site 0145), XI An, Shanxi

West China Hospital of Sichuan University ( Site 0147), Chengdu, Sichuan

Tianjin Medical University Cancer Institute & Hospital ( Site 0155), Tianjin, Tianjin

The First Affiliated Hospital Zhejiang University ( Site 0136), Hangzhou, Zhejiang

Zhejiang Cancer Hospital ( Site 0134), Hangzhou, Zhejiang

CHU Bordeaux Haut-Leveque Centre Francois Magendie ( Site 0245), Pessac Cedex, Gironde

A.P.H. Paris, Hopital Beaujon ( Site 0247), Clichy, Hauts-de-Seine

CHU de Montpellier - Hopital Saint-Eloi ( Site 0248), Montpellier, Herault

Centre Eugene Marquis ( Site 0242), Rennes, Ille-et-Vilaine

CHU Clermont-Ferrand - Site Estaing ( Site 0249), Clermont-Ferrand, Puy-de-Dome

Gustave Roussy ( Site 0244), Villejuif, Val-de-Marne

Universitaetsklinikum Ulm ( Site 0267), Ulm, Baden-Wurttemberg

Klinikum der Ludwig - Maximilian Universitat Munchen ( Site 0264), Muenchen, Bayern

Krankenhaus Nordwest ( Site 0266), Frankfurt, Hessen

Medizinische Hochschule Hannover ( Site 0265), Hannover, Niedersachsen

Universitaetsklinikum Aachen AOER ( Site 0275), Aachen, Nordrhein-Westfalen

Universitaetsklinikum Essen ( Site 0273), Essen, Nordrhein-Westfalen

Universitaetsklinikum Koeln ( Site 0274), Koeln, Nordrhein-Westfalen

Universitaetsklinikum Magdeburg A.o.R. ( Site 0271), Magdeburg, Sachsen-Anhalt

Staedtisches Klinikum Dresden ( Site 0272), Dresden, Sachsen

Charite - Universtitatsmedizin Berlin CCM ( Site 0269), Berlin, Not set

Universitaetsklinikum Hamburg-Eppendorf ( Site 0268), Hamburg, Not set

Pamela Youde Nethersole Eastern Hospital ( Site 0857), Hong Kong, Not set

Prince of Wales Hospital ( Site 0855), Hong Kong, Not set

Princess Margaret Hospital. ( Site 0856), Hong Kong, Not set

Queen Mary Hospital ( Site 0851), Hong Kong, Not set

Queen Elizabeth Hospital. ( Site 0854), Kowloon, Not set

Cork University Hospital ( Site 0538), Cork, Not set

Bon Secours Hospital ( Site 0526), Cork, Not set

Tallaght University Hospital ( Site 0522), Dublin, Not set

St Vincents University Hospital ( Site 0521), Dublin, Not set

Rambam Medical Center ( Site 0308), Haifa, Not set

Hadassah Ein Karem - Sharett Institute of Oncology ( Site 0309), Jerusalem, Not set

Rabin Medical Center ( Site 0307), Petah Tikva, Not set

Sourasky Medical Center ( Site 0306), Tel Aviv, Not set

Universita Cattolica del Sacro Cuore - Policlinico Gemelli ( Site 0329), Rome, Abruzzo

Policlinico S. Orsola-Malpighi ( Site 0333), Bologna, Not set

A.O. di Rilievo Nazionale e di alta Specializzazione Garibaldi ( Site 0330), Catania, Not set

ASST Grande Ospedale Metropolitano Niguarda ( Site 0332), Milano, Not set

Azienda Ospedaliero Universitaria Pisana ( Site 0326), Pisa, Not set

Policlinico Universitario Campus Biomedico ( Site 0328), Roma, Not set

Azienda Ospedaliera Universitaria di Verona ( Site 0334), Verona, Not set

Aichi Cancer Center Hospital ( Site 0080), Nagoya, Aichi

National Cancer Center Hospital East ( Site 0081), Kashiwa, Chiba

Kobe City Medical Center General Hospital ( Site 0087), Kobe, Hyogo

Kagawa University Hospital ( Site 0086), Kita-gun, Kagawa

Kanagawa Cancer Center ( Site 0079), Yokohama, Kanagawa

Osaka University Hospital ( Site 0085), Suita, Osaka

Kyorin University Hospital ( Site 0077), Mitaka, Tokyo

National Hospital Organization Kyushu Cancer Center ( Site 0078), Fukuoka, Not set

Kyoto University Hospital ( Site 0083), Kyoto, Not set

Osaka International Cancer Institute ( Site 0084), Osaka, Not set

The Cancer Institute Hospital of JFCR ( Site 0082), Tokyo, Not set

Chonnam National University Hwasun Hospital ( Site 0837), Hwasun Gun, Jeonranamdo

Seoul National University Bundang Hospital ( Site 0833), Seongnam-si, Kyonggi-do

CHA Bundang Medical Center CHA University ( Site 0835), Seongnam, Kyonggi-do

Ajou University Hospital, Clinical Research Center ( Site 0838), Suwon-si, Kyonggi-do

Kyungpook National University Chilgok Hospital ( Site 0834), Daegu, Taegu-Kwangyokshi

Chungnam National University Hospital ( Site 0840), Daejeon, Taejon-Kwangyokshi

Severance Hospital Yonsei University Health System ( Site 0836), Seoul, Not set

Asan Medical Center ( Site 0830), Seoul, Not set

Samsung Medical Center ( Site 0831), Seoul, Not set

The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 0839), Seoul, Not set

Korea University Guro Hospital ( Site 0832), Seoul, Not set

Hospital Sultan Ismail ( Site 0772), Johor Bahru, Johor

University Malaya Medical Centre ( Site 0770), Lembah Pantai, Kuala Lumpur

Hospital Pulau Pinang ( Site 0773), Georgetown, Pulau Pinang

Institut Kanser Negara - National Cancer Institute ( Site 0767), Putrajaya, Wilayah Persekutuan Putrajaya

Hospital Kuala Lumpur ( Site 0768), Kuala Lumpur, Not set

Pantai Hospital Kuala Lumpur ( Site 0771), Kuala Lumpur, Not set

Maastricht University Medical Centre ( Site 0347), Maastricht, Limburg

AMC ( Site 0348), Amsterdam, Noord-Holland

Erasmus University Medical Center ( Site 0352), Rotterdam, Zuid-Holland

UMCG ( Site 0349), Groningen, Not set

Universitair Medisch Centrum Utrecht ( Site 0351), Utrecht, Not set

Auckland City Hospital ( Site 0725), Auckland, Not set

Hospital Universitario General de Asturias ( Site 0434), Oviedo, Asturias

Hospital General Universitari Vall d Hebron ( Site 0432), Barcelona, Not set

Hospital General Universitario Gregorio Maranon ( Site 0433), Madrid, Not set

Hospital Universitario HM Sanchinarro ( Site 0435), Madrid, Not set

Hospital Regional Universitario Carlos Haya ( Site 0431), Malaga, Not set

Taipei Veterans General Hospital ( Site 0861), Taipei,, Taipei

Chang Gung Medical Foundation. Kaohsiung Branch ( Site 0865), Kaohsiung, Not set

China Medical University Hospital ( Site 0862), Taichung, Not set

National Cheng Kung University Hospital ( Site 0864), Tainan, Not set

National Taiwan University Hospital ( Site 0860), Taipei, Not set

Koo Foundation Sun Yat-Sen Cancer Center ( Site 0863), Taipei, Not set

Chang Gung Medical Foundation. Linkou ( Site 0853), Taoyuan, Not set

King Chulalongkorn Memorial Hospital ( Site 0884), Bangkok, Krung Thep Maha Nakhon

Ramathibodi Hospital. ( Site 0889), Bangkok, Krung Thep Maha Nakhon

Siriraj Hospital ( Site 0888), Bangkok, Krung Thep Maha Nakhon

Sunpasithiprasong Hospital ( Site 0883), Ubonratchathani, Ubon Ratchathani

Maharaj Nakorn Chiang Mai Hospital ( Site 0887), Chiang Mai, Not set

Srinagarind Hospital ( Site 0885), Khon Kaen, Not set

Udon Thani Cancer Hospital ( Site 0886), Udon Thani, Not set

Inonu Universitesi Medical Fakultesi ( Site 0501), Malatya, Adana

Baskent University Adana Training Hospital ( Site 0499), Adana, Not set

Hacettepe University Faculty of Medicine ( Site 0498), Ankara, Not set

Abdurrahman Yurtaslan Onkoloji Hastanesi ( Site 0494), Ankara, Not set

Gazi Universitesi Tip Fakultesi ( Site 0496), Ankara, Not set

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 0506), Istanbul, Not set

Göztepe Prof. Dr. Süleyman Yalçın Şehir Hastanesi-oncology ( Site 0495), Istanbul, Not set

Izmir Medical Park Hospital Department of Medical Oncology ( Site 0502), Izmir, Not set

Erciyes Universitesi Tip Fakultesi ( Site 0500), Kayseri, Not set

Aberdeen Royal Infirmary ( Site 0529), Aberdeen, Aberdeen City

Royal Free London NHS Foundation Trust ( Site 0520), London, London, City Of

Royal Marsden Hospital ( Site 0536), London, London, City Of

Imperial College Healthcare NHS Trust - Hammersmith Hospital ( Site 0525), London, London, City Of

Royal Marsden NHS Foundation Trust ( Site 0535), Sutton, Surrey

Belfast City Hospital ( Site 0517), Belfast, Not set

University Hospital Coventry and Warwickshire NHS Trust ( Site 0518), Coventry, Not set

The Christie NHS Foundation Trust ( Site 0537), Manchester, Not set

Conditions: Biliary Tract Carcinoma

Learn More ›

Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC

NCT04686305

Recruiting

DESTINY-Lung03 will investigate the safety and tolerability of trastuzumab deruxtecan in combination with Immunotherapy Agents with and without chemotherapy in patients with HER2 over-expressing non-small cell lung cancer. The efficacy will be also analyzed as a secondary endpoint.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/16/2025

Locations: Research Site, Duarte, California +79 locations

Research Site, Duarte, California

Research Site, Newport Beach, California

Research Site, Orange, California

Research Site, Santa Rosa, California

Research Site, Westwood, Kansas

Research Site, Baltimore, Maryland

Research Site, Detroit, Michigan

Research Site, Bronx, New York

Research Site, Buffalo, New York

Research Site, New York, New York

Research Site, Houston, Texas

Research Site, Fairfax, Virginia

Research Site, Tacoma, Washington

Research Site, Adelaide, Not set

Research Site, Heidelberg, Not set

Research Site, Nedlands, Not set

Research Site, Edegem, Not set

Research Site, Winnipeg, Manitoba

Research Site, London, Ontario

Research Site, Montreal, Quebec

Research Site, Bordeaux Cedex, Not set

Research Site, Dijon, Not set

Research Site, Pierre-Benite, Not set

Research Site, Saint Herblain, Not set

Research Site, Villejuif Cedex, Not set

Research Site, Kfar-Saba, Not set

Research Site, Tel Hashomer, Not set

Research Site, Milano, Not set

Research Site, Monza, Not set

Research Site, Napoli, Not set

Research Site, Padova, Not set

Research Site, Cheongju-si, Not set

Research Site, Goyang-si, Not set

Research Site, Jinju-si, Not set

Research Site, Seoul, Not set

Research Site, George Town, Not set

Research Site, Kuala Lumpur, Not set

Research Site, Kuching, Not set

Research Site, Selangor, Not set

Research Site, Amsterdam, Not set

Research Site, Bacolod, Not set

Research Site, Cebu City, Not set

Research Site, Davao City, Not set

Research Site, Manila, Not set

Research Site, Quezon City, Not set

Research Site, San Juan, Not set

Research Site, Taguig City, Not set

Research Site, Gdańsk, Not set

Research Site, Kraków, Not set

Research Site, Olsztyn, Not set

Research Site, Tomaszów Mazowiecki, Not set

Research Site, Warszawa, Not set

Research Site, Singapore, Not set

Research Site, Badalona, Not set

Research Site, Madrid, Not set

Research Site, Sevilla, Not set

Research Site, Valencia, Not set

Research Site, Kaohsiung city, Not set

Research Site, Taichung City, Not set

Research Site, Taichung, Not set

Research Site, Tainan, Not set

Research Site, Taipei, Not set

Research Site, Taoyuan, Not set

Research Site, Bangkok, Not set

Research Site, Hat Yai, Not set

Research Site, Khon Kaen, Not set

Research Site, Muang, Not set

Research Site, Ankara, Not set

Research Site, Bornova-Izmir, Not set

Conditions: Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Learn More ›

Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma

NCT02436707

Active Not Recruiting

The purpose of this study is to find out what effects new combinations of treatment will have this disease. New promising treatment strategies will be added to this study as they are available to be compared against the standard treatment.

Gender:

ALL

Ages:

Between 16 years and 65 years

Trial Updated:

04/14/2025

Locations: Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta +12 locations

Conditions: Lymphoma

Learn More ›

Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer

NCT06783140

Not Yet Recruiting

This study will compare two different regimens for patients with BRCA1/2 or PALB2 mutated metastatic pancreatic cancer after progression on first-line FOLFIRINOX.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

04/11/2025

Locations: Princess Margaret Cancer Centre, Toronto, Ontario

Conditions: Pancreatic Cancer, Advanced or Metastatic, BRCA1/2 Mutation, PALB2 Gene Mutation

Learn More ›

A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT04974398

Active Not Recruiting

This study is a randomized, double-blind, multi-center phase III clinical study to compare the efficacy and safety of penpulimab combined with chemotherapy and placebo combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma.

Gender:

ALL

Ages:

Between 12 years and 75 years

Trial Updated:

04/10/2025

Locations: City of Hope, Duarte, California +55 locations

City of Hope, Duarte, California

Winship Cancer Institute/Emory University, Atlanta, Georgia

University of Michigan, Ann Arbor, Michigan

Icahn School of Medicine at Mount Sinai, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

Chris O'Brien Lifehouse, Camperdown, New South Wales

St Vincent's Public Hospital Sydney, Darlinghurst, New South Wales

Genesis Care North Shore, St Leonards, New South Wales

Sir Charles Gardner, Heidelberg, Victoria

Austin Health, Nedlands, Western Australia

Hospital de Câncer de Barretos - Fundação Pio XII, Barretos, Reg1

Grupo Oncoclínicas, Botafogo, Reg1

Hospital Bruno Born, Lajeado, Reg1

Hospital Nossa Senhora da Conceicao, Porto Alegre, Reg1

Centro de Estudos e Pesquisa de Hematologia, Santo André, Reg1

Instituto do Câncer do Estado de São Paulo (ICESP), São Paulo, Reg1

Centro de Câncer A. C. Camargo, São Paulo, Reg1

Alberta Health Services (Tom Baker Cancer Centre), Calgary, Alberta

Toronto Sunnybrook Hospital, Toronto, Ontario

The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui

Fujian Cancer Hospital, Fuzhou, Fujian

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian

Dongguan People's Hospital, Dongguan, Guangdong

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong

Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong

Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong

The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong

The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Guangdong

Guangzhou Panyu Central Hospital, Guangzhou, Guangdong

Jiangmen Central Hospital, Jiangmen, Guangdong

Cancer Hospital of Shantou University Medical College, Shantou, Guangdong

Shenzhen People's Hospital, Shenzhen, Guangdong

Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong

The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong

Affiliated Hospital of Guilin Medical University, Guilin, Guangxi

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi

Guangxi Medical University Cancer Hospital, Nanning, Guangxi

The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi

Guizhou Cancer Hospital, Guiyang, Guizhou

The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan

Hainan General Hospital, Haikou, Hainan

Hubei Cancer Hospital, Wuhan, Hubei

The Second Xiangya Hospital of Central South University, Changsha, Hunan

Hunan Cancer Hospital, Changsha, Hunan

The First Affiliated Hospital of University of South China, Hengyang, Hunan

The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi

Jiangxi Cancer Hospital, Nanchang, Jiangxi

Fudan University Shanghai Cancer Center, Shanghai, Shanghai

Sichuan Cancer Hospital, Chengdu, Sichuan

The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan

Yunnan Cancer Hospital, Kunming, Yunnan

Zhejiang Cancer Hospital, Hangzhou, Zhejiang

Taizhou Hospital of Zhejiang Province, Taizhou, Zhejiang

Conditions: Nasopharyngeal Carcinoma

Learn More ›